107.522 articles found

Neurotoxicological and neuroprotective elements in Parkinson's disease.

Kostrzewa RM, Segura-Aguilar J.

Neurotox Res · 2002-03-01

DOI: 10.1080/10298420290015890PMID: 12829406

Neuroprotection in Parkinson's disease; a commentary.

Gatto EM, Riobó N, Carreras MC, Poderoso JJ, Micheli FE.

Neurotox Res · 2002-03-01

DOI: 10.1080/10298420290015881PMID: 12829414

Exercise training and Parkinson's disease: placebo or essential treatment?

Reuter I, Engelhardt M.

Phys Sportsmed · 2002-03-01

DOI: 10.3810/psm.2002.03.200PMID: 20086518

Compositions for the treatment of Parkinson's disease containing a CB1 receptor antagonist and a product that activates the dopaminergic neurotransmission in the brain.

Benavides Jesus, Boccio Daniel, Henin Yvette, Piot-Grosjean Odile.

· 2002-02-28

Brain potential signs of slowed stimulus processing following cholecystokinin in Parkinson's disease.

Smolnik R, Fischer S, Hagenah J, Kis B, Born J, Vieregge P.

Psychopharmacology (Berl) · 2002-02-19

DOI: 10.1007/s00213-002-1010-9PMID: 11967633

Segment difficulty in two-stroke movements in patients with Parkinson's disease.

Rand MK, Van Gemmert AW, Stelmach GE.

Exp Brain Res · 2002-02-16

DOI: 10.1007/s00221-002-1000-5PMID: 11889516

TREATMENT OF PARKINSON'S DISEASE BY THE COMBINED ACTION OF A COMPOUND WITH NEUROTROPHIC ACTIVITY AND A COMPOUND ENHANCING THE DOPAMINE ACTIVITY

PETERS Dan, RÏNN Lars Christian B., OLSEN Gunnar M., MÏLLER Arne.

· 2002-02-15

TREATMENT OF PARKINSON'S DISEASE BY THE COMBINED ACTION OF A COMPOUND WITH NEUROTROPHIC ACTIVITY AND A COMPOUND ENHANCING THE DOPAMINE ACTIVITY

MöLLER Arne, OLSEN Gunnar M., PETERS Dan NeuroSearch A/S, RÖNN Lars Christian B..

· 2002-02-15

Proanthocyanidins for the treatment of amyloid and alpha-synuclein diseases such as alzheimer's disease and parkinson's

SNOW ALAN D, CASTILLO GERALDO M, CHOI PAULA Y, NGUYEN BETH P.

· 2002-02-15

Neuroimmunophilin ligands in the treatment of Parkinson's disease.

Gold BG, Nutt JG.

Curr Opin Pharmacol · 2002-02-01

DOI: 10.1016/s1471-4892(01)00125-4PMID: 11786313

Health related quality of life in Parkinson's disease: a systematic review of disease specific instruments.

Marinus J, Ramaker C, van Hilten JJ, Stiggelbout AM.

J Neurol Neurosurg Psychiatry · 2002-02-01

DOI: 10.1136/jnnp.72.2.241PMID: 11796776

No male predominance in alpha-synuclein Parkinson's disease but the affected female fetus might be less viable.

Horstink MW, Bloem BR.

J Neurol Neurosurg Psychiatry · 2002-02-01

DOI: 10.1136/jnnp.72.2.276PMID: 11796789